Medical Research Council

NCT03129113

CollaboratorPhase 2/3Completed201790 people26 Apr 2017clinicaltrials.gov

NCT01247870

CollaboratorPhase 4Completed201152 people24 Nov 2010clinicaltrials.gov

NCT01130376

CollaboratorPhase 1Terminated200912 people26 May 2010clinicaltrials.gov

NCT00966888

Phase 3Status unknown20063,500 people27 Aug 2009clinicaltrials.gov

NCT00626990

CollaboratorPhase 3Active, not recruiting2007751 people29 Feb 2008clinicaltrials.gov

NCT00609856

CollaboratorPhase 4Completed200436 people7 Feb 2008clinicaltrials.gov

NCT00492258

Phase 3Completed20071,656 people27 Jun 2007clinicaltrials.gov

NCT00463827

CollaboratorPhase 2Completed200771 people20 Apr 2007clinicaltrials.gov

NCT00403065

Phase 3Completed20061,000 people23 Nov 2006clinicaltrials.gov

NCT00395200

CollaboratorPhase 1/2Completed200810 people2 Nov 2006clinicaltrials.gov

NCT00303784

CollaboratorPhase 3Status unknown20062,200 people17 Mar 2006clinicaltrials.gov

NCT00301782

Phase 2Completed200588 people13 Mar 2006clinicaltrials.gov

NCT00268476

Phase 2/3Active, not recruiting200511,992 people22 Dec 2005clinicaltrials.gov

NCT00253591

Phase 2/3Completed2005500 people15 Nov 2005clinicaltrials.gov

NCT00180713

CollaboratorPhase 1/2Completed200542 people16 Sept 2005clinicaltrials.gov

NCT00142324

CollaboratorPhase 4Status unknown2003190 people2 Sept 2005clinicaltrials.gov

NCT00135226

CollaboratorPhase 4Active, not recruiting200515,480 people25 Aug 2005clinicaltrials.gov

NCT00134030

CollaboratorPhase 3Completed20051,334 people24 Aug 2005clinicaltrials.gov

NCT00125593

CollaboratorPhase 4Completed20039,438 people1 Aug 2005clinicaltrials.gov

NCT00002477

Phase 3Status unknown199126 May 2004clinicaltrials.gov

Direct Pharmacological Activation of AMPK Extends Lifespan in Yeast, Worms and Flies

MC-M302-M34501 Oct 2026pubmed.ncbi.nlm.nih.gov

GLP-1 receptor agonists-a potential therapy for chronic kidney disease?

MR/V028723/11 Oct 2026pubmed.ncbi.nlm.nih.gov

Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All-Cause Mortality

MR/R024065/11 Oct 2026pubmed.ncbi.nlm.nih.gov

Defective HIRA driven chromatin maintenance underlies age related decline in oocyte quality

MC_US_A652_5PY7029 Sept 2026api.crossref.org

Clinically Recognised Alcohol Use Disorder and Risk of Dementia Subtypes in 1.3 Million Women: A Prospective Cohort Study

UKRI146429 Sept 2026api.crossref.org

Mitochondrial membrane lipid cardiolipin controls fiber-type adaptations in aging muscle via estrogen-related receptor γ

MC_UU_00028/529 Sept 2026pubmed.ncbi.nlm.nih.gov

Population-scale plasma proteomics reveals pre-diagnostic biomarkers and shared pathways of cancer risk across 25 cancers

MR/N003284/1, MC-UU_12015/1, MC_UU_00006/1, MR/Y013662/123 Sept 2026api.crossref.org

Adenosine Deaminase-Mediated Purine Dysfunction Leads to DNA Repair Inhibition and Senescence in Sporadic Amyotrophic Lateral Sclerosis

MR/W00416X/116 Sept 2026api.crossref.org

Alcohol use disorder is linked to higher dementia risk in women

medRxiv30 Sept 2026

Multilayered childhood adversity and mortality: a population-based cohort study of 1.2 million individuals

The Lancet regional health. Europe24 Sept 2026

Prevalence of target organ damage in rural Kenya and The Gambia: a cross-sectional study

The Lancet regional health. Africa13 Sept 2026

Co-Production of A Culturally Tailored Sarcopenia Screening Programme for Older Adults in Luton, UK: A Mixed-Methods Feasibility Study Protocol

Journal of frailty, sarcopenia and falls3 Sept 2026